Bicycle Therapeutics (BCYC)
NASDAQ: BCYC
· Real-Time Price · USD
7.45
0.07 (0.95%)
At close: Aug 15, 2025, 3:59 PM
7.98
7.11%
After-hours: Aug 15, 2025, 07:33 PM EDT
Bicycle Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 721.45M | 792.97M | 879.52M | 890.86M | 961.36M | 457M | 526.42M | 572.09M | 340.43M | 293.81M | 339.15M | 361.47M | 372.77M | 407.37M | 438.68M | 259.52M | 198.74M | 195.9M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 547K | 547K | 547K | 547K | 547K | 547K | 547K | 548K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 13.26M | 11.81M | 10.53M | 9.39M | 6.03M | 5.82M | 5.25M | 4.9M | 12.15M | 10.57M | 8.46M | 6.16M | 5.1M | 4.2M | 3.45M | 2.78M | 2.38M | 2.18M |
Receivables | 60.75M | 46.37M | 35.65M | 57.98M | 46.68M | 39.06M | 24.04M | 17.28M | 57.97M | 76.51M | 21.21M | 11.37M | 26.27M | 13.33M | 11.91M | 7.7M | 14.26M | 13.53M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 22.06M | 16.74M | 13.43M | 17.35M | 20.22M | 19.9M | 11.41M | 13.67M | 10.02M | 10.93M | 9.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 804.26M | 856.09M | 928.61M | 966.19M | 1.03B | 515.96M | 561.87M | 603.04M | 408.43M | 381.25M | 369.38M | 381.29M | 408.49M | 429.77M | 458.56M | 272.87M | 217.79M | 215.39M |
Property-Plant & Equipment | 14.11M | 15.45M | 17.19M | 20.61M | 22.52M | 24.81M | 27.68M | 30.2M | 33.59M | 36.98M | 32.77M | 29.7M | 31.89M | 25.6M | 17.79M | 5.68M | 5.88M | 6.27M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 27.92M | 27.81M | 28.26M | 30.55M | 29.1M | 31.18M | 33.48M | 35.65M | 45.74M | 47.55M | 41.23M | 35.86M | 36.99M | 29.8M | 21.24M | 8.46M | 8.26M | 8.45M |
Total Assets | 832.18M | 883.89M | 956.87M | 996.75M | 1.06B | 547.14M | 595.34M | 638.68M | 454.17M | 428.8M | 410.61M | 417.15M | 445.48M | 459.56M | 479.79M | 281.33M | 226.05M | 223.84M |
Account Payables | 18.26M | 11.11M | 15.79M | 5.71M | 7.45M | 7.06M | 13.05M | 8.49M | 5.25M | 2.81M | 6.47M | 7.06M | 4.86M | 4M | 2.72M | 1.76M | 3.47M | 996K |
Deferred Revenue | 14.62M | 12.52M | 10.19M | 11.38M | 11.62M | 16.42M | 24.98M | 27.19M | 29.75M | 24.97M | 20.42M | 16.4M | 19.53M | 19.15M | 19.27M | 17.46M | 8.74M | 10.09M |
Short-Term Debt | 5.43M | 5.72M | 5.5M | 5.55M | 22.4M | 4.97M | 4.88M | 4.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 6.12M | 22.56M | 11.07M | 15.22M | 13.8M | 743K | 8.36M | 5.4M | 23.55M | 13.72M | 13.4M | 8.95M | 5.51M | 6.6M | 7M | 4.25M | 2.88M | 1.86M |
Total Current Liabilities | 77.42M | 57.62M | 67.23M | 56.41M | 69.61M | 49.51M | 69.54M | 69.74M | 72.27M | 52.99M | 53.34M | 41.55M | 41.34M | 35.41M | 36.24M | 30.18M | 23.27M | 20.81M |
Long-Term Debt | n/a | n/a | n/a | 5.53M | 8.51M | 30.8M | 30.7M | 30.6M | 30.51M | 30.42M | 30.32M | 30.23M | 30.14M | 30.01M | 29.87M | 29.75M | 29.63M | 29.5M |
Other Long-Term Liabilities | 1.14M | 1.12M | 1.12M | 5.96M | 4.7M | 4.61M | 4.58M | 4.32M | 4.33M | 4.08M | 3.83M | 3.16M | 3.26M | 3.36M | 3.28M | 3.04M | 2.96M | 2.81M |
Total Long-Term Liabilities | 85.85M | 85.94M | 96.58M | 109.31M | 113.93M | 141.59M | 154.88M | 152.93M | 161.81M | 132.64M | 86.48M | 86.12M | 92.75M | 93.89M | 97.3M | 80.33M | 60.73M | 60.95M |
Total Liabilities | 163.27M | 143.56M | 163.81M | 165.71M | 183.54M | 191.09M | 224.41M | 222.66M | 234.07M | 185.64M | 139.83M | 127.67M | 134.09M | 129.31M | 133.54M | 110.51M | 84M | 81.75M |
Total Debt | 7.2M | 8.32M | 9.49M | 11.09M | 42.74M | 43.82M | 44.96M | 45.69M | 47.07M | 49.47M | 44.33M | 44.04M | 45.55M | 47.1M | 44.34M | 33.07M | 33.2M | 33.23M |
Common Stock | 893K | 892K | 890K | 890K | 889K | 553K | 550K | 550K | 396K | 389K | 387K | 385K | 385K | 385K | 384K | 329K | 309K | 300K |
Retained Earnings | -820.5M | -741.54M | -680.79M | -628.94M | -578.13M | -538.32M | -511.76M | -462.66M | -412.76M | -370.16M | -331.1M | -301.12M | -272.77M | -245.94M | -218.38M | -200.34M | -185.66M | -167.75M |
Comprehensive Income | -3.36M | -1.46M | 119K | -3.19M | -1.09M | -778K | -1.3M | 2.88M | -877K | 71K | 387K | 528K | -374K | -2.47M | -3.39M | -3.19M | -3.51M | -3.25M |
Shareholders Equity | 668.91M | 740.33M | 793.06M | 831.03M | 873.81M | 356.05M | 370.93M | 416.02M | 220.1M | 243.16M | 270.78M | 289.47M | 311.39M | 330.26M | 346.25M | 170.82M | 142.05M | 142.09M |
Total Investments | 547K | 547K | 547K | 547K | 547K | 547K | 547K | 548K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |